Loading...
•
Jun 30
Rockwell Medical Q2 2025 Earnings Report
Rockwell Medical reported a decrease in net sales and a net loss for the second quarter of 2025, while managing a customer transition and focusing on cost efficiencies.
Key Takeaways
Rockwell Medical experienced a significant decline in net sales and reported a net loss for Q2 2025, primarily due to the transition of its largest customer. Despite this, the company is focusing on new customer acquisition, contract renewals, and cost management to improve gross margin and adjusted EBITDA.
Net sales for Q2 2025 were $16.1 million, a decrease from $25.8 million in Q2 2024.
The company reported a net loss of $1.5 million for Q2 2025, compared to a net income of $0.3 million in Q2 2024.
Adjusted EBITDA for Q2 2025 was a loss of $0.2 million, down from a positive $1.4 million in the prior year.
Rockwell Medical is actively bringing on new customers, both domestically and internationally, and has over 80% of its customers under long-term contracts.
Rockwell Medical
Rockwell Medical
Forward Guidance
Rockwell Medical confirmed its full-year 2025 guidance, expecting net sales between $65.0 million and $70.0 million, gross margin between 16% and 18%, and adjusted EBITDA between a loss of $0.5 million and a gain of $0.5 million.
Positive Outlook
- Confirmed 2025 annual guidance for net sales, gross margin, and adjusted EBITDA.
- Focus on managing expenses and manufacturing products more cost-effectively to improve gross margin.
- Efforts to drive profitability on an Adjusted EBITDA basis.
- Continued acquisition of new customers, both domestically and internationally.
- Active renewal of contracts with existing customers, with over 80% under long-term contracts.
Challenges Ahead
- Net sales guidance range indicates potential for continued revenue decline compared to previous year's performance.
- Adjusted EBITDA guidance includes a potential loss, indicating ongoing profitability challenges.
- Gross margin guidance is relatively low, suggesting continued pressure on profitability.
- The company is still navigating the transition away from its largest customer, which impacted Q2 results.
- No specific positive guidance on net income or EPS, which were negative in the current quarter.